LABFF
Price
$90.61
Change
+$4.56 (+5.30%)
Updated
Jul 1 closing price
Capitalization
2.79B
NVO
Price
$68.24
Change
+$0.21 (+0.31%)
Updated
Apr 2 closing price
Capitalization
308.32B
34 days until earnings call
Ad is loading...

LABFF vs NVO

Header iconLABFF vs NVO Comparison
Open Charts LABFF vs NVOBanner chart's image
LABORATORIOS FARMACEUTICOS ROVI SA
Price$90.61
Change+$4.56 (+5.30%)
Volume$100
Capitalization2.79B
Novo-Nordisk A/S
Price$68.24
Change+$0.21 (+0.31%)
Volume$7.34M
Capitalization308.32B
LABFF vs NVO Comparison Chart
Loading...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LABFF vs. NVO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LABFF is a Hold and NVO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (LABFF: $90.61 vs. NVO: $68.24)
Brand notoriety: LABFF and NVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LABFF: 100% vs. NVO: 92%
Market capitalization -- LABFF: $2.79B vs. NVO: $308.32B
LABFF [@Biotechnology] is valued at $2.79B. NVO’s [@Biotechnology] market capitalization is $308.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LABFF’s FA Score shows that 2 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).

  • LABFF’s FA Score: 2 green, 3 red.
  • NVO’s FA Score: 2 green, 3 red.
According to our system of comparison, LABFF is a better buy in the long-term than NVO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVO’s TA Score shows that 4 TA indicator(s) are bullish.

  • NVO’s TA Score: 4 bullish, 6 bearish.

Price Growth

LABFF (@Biotechnology) experienced а 0.00% price change this week, while NVO (@Biotechnology) price change was -3.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

NVO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($308B) has a higher market cap than LABFF($2.79B). LABFF has higher P/E ratio than NVO: LABFF (28.85) vs NVO (20.80). LABFF YTD gains are higher at: 0.000 vs. NVO (-19.391). NVO has higher annual earnings (EBITDA): 137B vs. LABFF (208M). NVO has higher revenues than LABFF: NVO (290B) vs LABFF (764M).
LABFFNVOLABFF / NVO
Capitalization2.79B308B1%
EBITDA208M137B0%
Gain YTD0.000-19.391-
P/E Ratio28.8520.80139%
Revenue764M290B0%
Total Cash27.4MN/A-
Total Debt114MN/A-
FUNDAMENTALS RATINGS
NVO: Fundamental Ratings
NVO
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
56
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVO
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bearish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Advances
ODDS (%)
Bullish Trend 17 days ago
67%
Declines
ODDS (%)
Bearish Trend 7 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
54%
View a ticker or compare two or three
Ad is loading...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCMVX19.190.22
+1.16%
Monongahela All Cap Value
CBBYX6.38N/A
N/A
AB Relative Value Advisor
OWSMX15.86N/A
N/A
Old Westbury Small & Mid Cap Strategies
IYPCX18.57N/A
N/A
Macquarie Systematic Em Mkts Eq R
GQHPX13.53N/A
N/A
GQG Partners US Quality Value Fund Inv

LABFF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LABFF has been closely correlated with IMRN. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if LABFF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LABFF
1D Price
Change %
LABFF100%
N/A
IMRN - LABFF
81%
Closely correlated
N/A
MNMD - LABFF
47%
Loosely correlated
+7.76%
CELZ - LABFF
35%
Loosely correlated
+7.00%
NVO - LABFF
29%
Poorly correlated
+0.31%
QSI - LABFF
26%
Poorly correlated
+2.50%
More

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been closely correlated with NONOF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVO jumps, then NONOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.31%
NONOF - NVO
70%
Closely correlated
+0.98%
GALT - NVO
34%
Loosely correlated
+4.76%
BCAB - NVO
32%
Poorly correlated
-3.88%
AXON - NVO
29%
Poorly correlated
+3.18%
LABFF - NVO
29%
Poorly correlated
N/A
More